| 3DG | 3-deoxyglucosone |
| AGEs | Advanced glycation endproducts |
| CEL | Nε-(1-carboxyethyl)lysine |
| CFA | Complete freund’s adjuvant |
| CML | Nε-(carboxymethyl)lysine |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| EAE | Experimental autoimmune encephalomyelitis |
| Glo-1 | Glyoxalase-1 |
| Glo-2 | Glyoxalase-2 |
| GO | Glyoxal |
| GSH | Glutathione |
| MG-H1 | Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine |
| MGO | Methylglyoxal |
| MOG | Myelin oligodendrocyte glycoprotein |
| MS | Multiple sclerosis |
| NF-κB | Nuclear factor-κB |
| RAGE | Receptor for advanced glycation endproducts |
| RR MS | Relapsing-remitting MS |
| SP MS | Secondary progressive MS |
| sRAGE | Soluble receptor for advanced glycation endproducts |
| UPLC MSMS | Ultra-performance liquid chromatography tandem mass spectrometry |